Cargando…

Molecular Epidemiological Study of Pyrazinamide-Resistance in Clinical Isolates of Mycobacterium tuberculosis from South India

Pyrazinamide (PZA) has been in use for almost 50 years as a first-line drug for short-course chemotherapy against Mycobacterium tuberculosis. In this study, PCR mediated automated DNA sequencing is used to check the prevalence of PZA resistance among treatment failure cases of pulmonary tuberculosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muthaiah, Muthuraj, Jagadeesan, Sridharan, Ayalusamy, Nisha, Sreenivasan, Manupriya, Prabhu, Sambamurthy Sangamesvara, Muthuraj, Usharani, Senthilkumar, Kamatchiyammal, Veerappan, Saroja
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920559/ https://www.ncbi.nlm.nih.gov/pubmed/20717529 http://dx.doi.org/10.3390/ijms11072670

Ejemplares similares

Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates
por: Muthaiah, Muthuraj, et al.
Publicado: (2017)

Prevalence and factors associated with multidrug-resistant tuberculosis in South India
por: Shivekar, Smita S., et al.
Publicado: (2020)

Molecular diagnosis, genetic diversity and drug sensitivity patterns of Mycobacterium tuberculosis strains isolated from tuberculous meningitis patients at a tertiary care hospital in South India
por: Krishnakumariamma, Krishnapriya, et al.
Publicado: (2020)

Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes
por: Vidyaraj, C.K., et al.
Publicado: (2017)

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021)

Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
por: Manca, Claudia, et al.
Publicado: (2013)

Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis
por: Ahmad, Zahoor, et al.
Publicado: (2012)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
por: Miotto, Paolo, et al.
Publicado: (2014)

The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
por: Sun, Qingan, et al.
Publicado: (2020)

Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
por: Santucci, Pierre, et al.
Publicado: (2021)

Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021)

Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates
por: Huy, Nguyen Quang, et al.
Publicado: (2017)

Predictors of Loss to Follow-Up among Men with Tuberculosis in Puducherry and Tamil Nadu, India
por: Zhou, Thomas J., et al.
Publicado: (2020)

Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea.
por: Lee, K. W., et al.
Publicado: (2001)

PncAgene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis
por: Untiveros, Katherine Lozano, et al.
Publicado: (2014)

Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis
por: Zhou, Shiyang, et al.
Publicado: (2017)

Rapid microarray-based assay for detection of pyrazinamide resistant Mycobacterium tuberculosis
por: Havlicek, Juliane, et al.
Publicado: (2019)

Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide
por: Petrella, Stéphanie, et al.
Publicado: (2011)

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis
por: Shi, Wanliang, et al.
Publicado: (2014)

Pyrazinamide Resistance, Mycobacterium tuberculosis Lineage and Treatment Outcomes in San Francisco, California
por: Budzik, Jonathan M., et al.
Publicado: (2014)

Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis
por: Whitfield, Michael G., et al.
Publicado: (2022)

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
por: Shi, Dawei, et al.
Publicado: (2022)

Insight to pyrazinamide resistance inMycobacterium tuberculosisby molecular docking
por: Unissa, Amirudeen Nusrath, et al.
Publicado: (2009)

Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis
por: Zhang, Shuo, et al.
Publicado: (2013)

The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
por: Pullan, Steven T., et al.
Publicado: (2016)

Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System
por: Demers, Anne-Marie, et al.
Publicado: (2016)

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
por: Kahbazi, Manijeh, et al.
Publicado: (2018)

Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis
por: Florentini, Edgar A., et al.
Publicado: (2020)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
por: Xia, Hui, et al.
Publicado: (2020)

Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India
por: Kan, Carolyn K., et al.
Publicado: (2020)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
por: Shi, Jie, et al.
Publicado: (2020)

Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis
por: Florentini, Edgar A., et al.
Publicado: (2021)

Activity of Pyrazinamide against Mycobacterium tuberculosis at Neutral pH in PZA-S1 Minimal Medium
por: Shi, Wanliang
Publicado: (2021)

Performance of Wayne assay for detection of pyrazinamide resistance in Mycobacterium tuberculosis: a meta-analysis study
por: Nasiri, M.J., et al.
Publicado: (2021)

Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration
por: Gumbo, Tawanda, et al.
Publicado: (2021)

IL-10 Modulation Increases Pyrazinamide’s Antimycobacterial Efficacy against Mycobacterium tuberculosis Infection in Mice
por: Dwivedi, Varun, et al.
Publicado: (2023)

Pyrazinamide resistance in rifampicin discordant tuberculosis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2022)

Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis
por: Brindle, Richard, et al.
Publicado: (2001)

Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh
por: Rahman, Arfatur, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0scilah39bmim83d3elq9nf7cj